The Breast Cancer Index test is the only guideline recognized test to predict whether your patient is likely to benefit from extended endocrine therapy. To learn more about the BCI tests' guideline recognition, visit bit.ly/3BUniTU. Hologic #findherfinish

The Breast Cancer Index® (BCI™) test has demonstrated consistent predictive evidence across 5 studies and over 4,700 patients. Make more confident extended endocrine recommendations with the BCI test. Learn more at bit.ly/3PnSi1T. Hologic #findherfinish #breastcancer

Are you making optimal extended endocrine therapy recommendations for your early-stage, HR+ breast cancer patients? Learn more at breastcancerindex.com #findherfinish

Linda Moors, PA-C, and her patient Cheryl used the Breast Cancer Index® test to make important decisions about her breast cancer treatment. Learn more at bit.ly/3FG1LQp

Help identify patients who may benefit from extended endocrine therapy to help avoid a potentially life-threatening metastatic recurrence with the Breast Cancer Index® test. To learn more, visit BreastCancerIndex.com

Happy Nurses Week 2025! This week, we honor the extraordinary nurses who work tirelessly to provide care and comfort for patients. From saving lives to lending a listening ear, you are the heart of healthcare.💕 Hologic #NursesWeek2025 #NurseAppreciation #HealthcareHeroes

The Breast Cancer Index® test provides a clear and easy to understand report that provides 2 main results. Visit BreastCancerIndex.com to learn more.

Today, on #CancerSurvivorsDay, we celebrate the strength of survivors everywhere. The Breast Cancer Index® test helps guide personalized care decisions about extended endocrine therapy, empowering every survivor. Visit BreastCancerIndex.com to learn more.

Presented at #ASCO25: Dr. Tara Sanft discusses the practice-changing impact of Breast Cancer Index® testing on providers recommendations related to extended endocrine therapy for patients with early-stage, HR+ breast cancer. bit.ly/45862XB

#CancerSurvivorsMonth 🌟 SURVIVOR SPOTLIGHT From breast cancer diagnosis to author - meet Michelle. To hear Michelle’s full story, visit bit.ly/3YPMVgX

#CancerSurvivorsMonth 🌟 SURVIVOR SPOTLIGHT From breast cancer diagnosis to empowerment - meet Ashliann. For Ashliann’s full story, visit bit.ly/3Q8RnCY

#CancerSurvivorsMonth 🌟 SURVIVOR SPOTLIGHT From breast cancer diagnosis to IRONMAN finisher—meet Cheryl. Hear Cheryl’s full story: bit.ly/3YejSDy

An interview with Oncology Nursing News® highlights how patient-centered care and tools like the Breast Cancer Index® test empower patients, helping them make informed extended endocrine treatment decisions with peace of mind. bit.ly/4k3ma0h

Breast cancer care is evolving. This Medscape article shows how genomic profiling helps providers personalize treatment for each patient. Individualized plans are the new standard. wb.md/4nsbdrk

Empower your patients with knowledge! Tools like the Breast Cancer Index® Test can support confident, personalized treatment planning. Michelle Kirschner shares expert tips with Oncology Nursing News for discussing Breast Cancer Index Testing with patients. bit.ly/46lYDmu

A recent article from ASCO Daily News® dives into the challenges of choosing optimal endocrine therapy duration for premenopausal breast cancer patients, highlighting the need for personalized care. bit.ly/4mpFoyv

Breast cancer treatment decisions can be complex. In this Oncology Nursing News interview, Michelle Kirschner shares how nurses can guide patients in personalizing endocrine therapy duration, highlighting shared decision-making and the BCI Test. bit.ly/3K4wyJ2

Myth busted: 5 years isn’t always enough for T1N0 patients.(1) The Breast Cancer Index® Test can help identify patients who may need 5 more years to reduce the risk of late distant recurrence. Are you personalizing your approach?​ Hologic #BustTheMyth #BCAM

One size doesn’t fit all. The Breast Cancer Index® Test can help identify which N1 patients are not likely to benefit from 5 additional years of endocrine therapy and help avoid unnecessary side effects. ​ Hologic #BustTheMyth #BreastCancerAwarenessMonth

When it comes to extended endocrine therapy, let data drive your decisions for optimal patient outcomes. Bottom line: Using an appropriate test matters!​ Hologic #BustTheMyth #BreastCancerAwarenessMonth